Guangzhou Pharmaceutical Co. Ltd. reported unaudited consolidated and company earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the consolidated company reported net profit attributable to shareholders was CNY 36,555,532.19 or CNY 0.045 per diluted share on income from operations of CNY 955,588,060.16 compared to net loss attributable to shareholders of CNY 22,251,554.02 or CNY 0.027 loss per diluted share on income from operations of CNY 658,388,901.78 for the same period a year ago. Operating profit was CNY 40,068,392.11 compared to operating loss of CNY 36,749,278.25 for the same period a year ago. Total profit was CNY 45,749,546.86 against total loss of CNY 35,259,934.41 for the same period a year ago. Net profit was CNY 35,613,614.39 against total net loss of CNY 27,413,053.71 for the same period a year ago. Total comprehensive income was CNY 35,914,524.89 against total comprehensive loss of CNY 28,569,771.14 for the same period a year ago. For the nine months, the consolidated company reported net profit attributable to shareholders was CNY 153,118,957.14 or CNY 0.189 per diluted share on income from operations of CNY 2,899,885,317.44 compared to net profit attributable to shareholders of CNY 144,371,259.45 or CNY 0.178 per diluted share on income from operations of CNY 2,761,801,498.24 for the same period a year ago. Operating profit was CNY 156,138,178.58 compared to CNY 156,195,899.79 for the same period a year ago. Total profit was CNY 169,949,347.02 against CNY 162,885,119.66 for the same period a year ago. Net profit was CNY 150,205,287.95 against CNY 144,849,186.21 for the same period a year ago. Total comprehensive income was CNY 151,961,905.65 against CNY 128,342,626.52 for the same period a year ago. Net cash flows from operating activities were CNY 333,455,442.08 against net cash used in operating activities of CNY 35,040,955.34 for the same period a year ago. For the quarter, the company reported net profit was CNY 39,325,906.83 on income from operations of CNY 217,933,539.33 compared to net profit of CNY 40,911,127.74 on income from operations of CNY 121,107,587.24 for the same period a year ago. Operating profit was CNY 38,575,447.28 compared to CNY 43,057,119.34 for the same period a year ago. Total profit was CNY 38,724,729.00 against CNY 42,542,611.74 for the same period a year ago. Total comprehensive income was CNY 39,777,453.66 against CNY 40,057,692.24 for the same period a year ago. For the nine months, the company reported net profit was CNY 161,540,091.92 on income from operations of CNY 591,845,759.58 compared to net profit of CNY 342,004,133.04 on income from operations of CNY 432,547,223.59 for the same period a year ago. Operating profit was CNY 164,879,932.93 compared to CNY 346,842,859.84 for the same period a year ago. Total profit was CNY 165,023,403.16 against CNY 346,381,343.94 for the same period a year ago. Total comprehensive income was CNY 162,501,438.47 against CNY 493,010,650.39 for the same period a year ago. Net cash used in operating activities was CNY 29,615,007.89 against CNY 10,474,158.69 for the same period a year ago.

Guangzhou Pharmaceutical Co. Ltd., Board Meeting, Oct 29, 2009 Agenda: To consider and approve the unaudited financial results of the company together with its subsidiaries for the 9 months ended 30 September 2009 and transacting any other business (if any).

Guangzhou Pharmaceutical Co. Ltd. reported unaudited consolidated earnings results for the six months ended June 30, 2009. For the period, the company reported profit attributable to shareholders was HKD 118,788,000 or HKD 0.146 basic and diluted earnings per share on revenue of HKD 1,903,008,000 compared to profit attributable to shareholders was HKD 149,463,000 or HKD 0.184 basic and diluted earnings per share on revenue of HKD 2,069,339,000 for the same period a year ago. Operating profit was HKD 48,328,000 and profit before income tax was HKD 123,579,000 compared to operating profit of HKD 115,692,000 and profit before income tax of HKD 180,420,000 for the same period a year ago. Net cash flow from operating activities was HKD 242,138,000 or HKD 0.299 per share and fully diluted return on net assets was 3.63% compared to net cash flow from operating activities of HKD 11,971,000 or HKD 0.015 per share and fully diluted return on net assets of HKD 5.36% for the same period a year ago. Actual expenditure amounted to HKD 26,000,000 compared to HKD 99,000,000 in the first half of 2008, which will be mainly applied in the construction of facilities and infrastructure and purchases of machines and equipment, etc. The Group expected that capital expenditure for the year 2009 will be approximately HKD 132,000,000.